Non-alcoholic fatty liver disease is associated with progression of arterial stiffness

N. Li, G. w. Zhang, J. r. Zhang, D. Jin, Y. Li, T. Liu, R. t. Wang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4±42.1cm/s for men, 95.8±36.7cm/s for women) than in the subjects without NAFLD (70.3±56.5cm/s for men, 55.4±42.2cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, β=0.843; P<0.001; for female, β=0.575; P<0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalNutrition, Metabolism and Cardiovascular Diseases
Volume25
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Vascular Stiffness
Pulse Wave Analysis
Ankle
Arm
Non-alcoholic Fatty Liver Disease
Disease Progression
Atherosclerosis
Cardiovascular Diseases
Prospective Studies
Hypertension

Keywords

  • Arterial stiffness
  • Brachial-ankle pulse wave velocity
  • Non-alcoholic fatty liver disease

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. / Li, N.; Zhang, G. w.; Zhang, J. r.; Jin, D.; Li, Y.; Liu, T.; Wang, R. t.

In: Nutrition, Metabolism and Cardiovascular Diseases, Vol. 25, No. 2, 01.02.2015, p. 218-223.

Research output: Contribution to journalArticle

Li, N. ; Zhang, G. w. ; Zhang, J. r. ; Jin, D. ; Li, Y. ; Liu, T. ; Wang, R. t. / Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. In: Nutrition, Metabolism and Cardiovascular Diseases. 2015 ; Vol. 25, No. 2. pp. 218-223.
@article{95762f347e464b1385364c69c27e60cb,
title = "Non-alcoholic fatty liver disease is associated with progression of arterial stiffness",
abstract = "Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4±42.1cm/s for men, 95.8±36.7cm/s for women) than in the subjects without NAFLD (70.3±56.5cm/s for men, 55.4±42.2cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, β=0.843; P<0.001; for female, β=0.575; P<0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness.",
keywords = "Arterial stiffness, Brachial-ankle pulse wave velocity, Non-alcoholic fatty liver disease",
author = "N. Li and Zhang, {G. w.} and Zhang, {J. r.} and D. Jin and Y. Li and T. Liu and Wang, {R. t.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.numecd.2014.10.002",
language = "English (US)",
volume = "25",
pages = "218--223",
journal = "Nutrition, Metabolism and Cardiovascular Diseases",
issn = "0939-4753",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Non-alcoholic fatty liver disease is associated with progression of arterial stiffness

AU - Li, N.

AU - Zhang, G. w.

AU - Zhang, J. r.

AU - Jin, D.

AU - Li, Y.

AU - Liu, T.

AU - Wang, R. t.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4±42.1cm/s for men, 95.8±36.7cm/s for women) than in the subjects without NAFLD (70.3±56.5cm/s for men, 55.4±42.2cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, β=0.843; P<0.001; for female, β=0.575; P<0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness.

AB - Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4±42.1cm/s for men, 95.8±36.7cm/s for women) than in the subjects without NAFLD (70.3±56.5cm/s for men, 55.4±42.2cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, β=0.843; P<0.001; for female, β=0.575; P<0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness.

KW - Arterial stiffness

KW - Brachial-ankle pulse wave velocity

KW - Non-alcoholic fatty liver disease

UR - http://www.scopus.com/inward/record.url?scp=84922069983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922069983&partnerID=8YFLogxK

U2 - 10.1016/j.numecd.2014.10.002

DO - 10.1016/j.numecd.2014.10.002

M3 - Article

C2 - 25456154

AN - SCOPUS:84922069983

VL - 25

SP - 218

EP - 223

JO - Nutrition, Metabolism and Cardiovascular Diseases

JF - Nutrition, Metabolism and Cardiovascular Diseases

SN - 0939-4753

IS - 2

ER -